Шифр: УУ60/2020/92/2
   Журнал

The Ukrainian biochemical journal [Текст]. - Виходит раз на два місяця
2020р. Т. 92 № 2
Зміст:
Vari, S. G. Homo scientist can lead HOMO SAPIENS to the next evolutionary stage, to HOMO ingenious / S. G. Vari. - P.5-6
Korolyuk, O. Ya. Hypertriclyceridemia is associated with long-term risk of cardiovascular events and specific comorbidity in very high-risk hypertensive patients / O. Ya. Korolyuk, O. M. Radchenko. - P.8-19
Bozhenko, M. Freezing influences, the exposure of IgG glycans in sera from multiple sclerosis patients / M. Bozhenko [et al.]. - P.21-31
Інші автори: Boichuk M., Bila G., Nehrych T., Bilyy R.
Nasadyuk, C. M. Lectinocytochemical study of rat stomach mucosa under the conditions of cyclooxygenase-1/-2 blockage and pretreatment with H-GLU-ASP-GLY-OH / C. M. Nasadyuk [et al.]. - P.33-43
Інші автори: Sogomonyan E. A., Yashchenko A. M., Sklyarov A. Y.
Onopchenko, O. V. The effect of N-stearoylethanolamine on the lipid composition of the rat testes and testosterone level during the early stages of streptozotocin-induced diabetes / O. V. Onopchenko [et al.]. - P.45-59
Інші автори: Horid’ko T. M., Kosiakova H. V., Berdyshev A. G., Klimashevsky V. M., Hula N. M.
Tkachenko, O. S. Protective action of N-stearoylethanolamine on blood coagulation and arterial changes in spontaneously hypertensive rats fed cholesterol-rich diet / O. S. Tkachenko [et al.]. - P.60-71
Інші автори: Hydz Ie. A., Kosiakova H. V., Klymenko P. P., Stohnii Y. M., Didkivskyi V. A., Chernyshenko T. M., Chernyshenko V. O., Platonova T. M.
Stohnii, Y. M. Aggregation of platelets, proliferation of endothelial cells and motility of cancer cells are mediated by the Bβ1(15)-42 residue of fibrin(ogen) / Y. M. Stohnii [et al.]. - P.72-85
Інші автори: Ryzhykova M. V., Rebriev A. V., Kuchma M. D., Marunych R. Y., Chernyshenko V. O., Shablii V. A., Lypova N. M., Slominskyi O. Yu., Garmanchhuk L. V., Platonova T. M., Komisarenko S. V.
Revenko, O. Exogenous hydrogen sulfide for the treatment of mesenteric damage associated with fructose-induced malfunctions via inhibition of oxidative stress / O. Revenko [et al.]. - P.86-98
Інші автори: Zaichko N., Wallace J., Zayachkivska O.
Bila, G. Novel approach for discrimination of eosinophilic granulocytes and evaluation of their surface receptors in a multicolor fluorescent histological assessment / G. Bila [et al.]. - P.99-107
Інші автори: Schneider M., Peshkova S., Krajnik B., Besh L., Lutsyk A., Matsyura O., Bilyy R.
Kryshchyshyn, A. Synthesis and anti-leukemic activity of pyrrolidinedione-thiazolidinone hybrids / A. Kryshchyshyn [et al.]. - P.108-120
Інші автори: Kaminskyy D., Roman O., Kralovics R., Karpenko O., Lesyk R.
Hreniukh, V. P. Effects of thiazole derivatives on intracellular structure and functions in murine lymphoma cells / V. P. Hreniukh [et al.]. - P.121-131
Інші автори: Finiuk N. S., Shalai Ya. R., Manko B. O., Manko B. V., Ostapiuk Yu. V., Kulachkovskyy O. R., Obushak M. D., Stoika R. S., Babsky A. M.
Chaban, T. I. Development of effective anti-inflammatory drug candidates among novel thiazolopyridines / T. I. Chaban [et al.]. - P.132-139
Інші автори: Matiychuk V. S., Ogurtsov V. V., Chaban I. G., Nektegayev I. A.
Є примірники у відділах:
Прим. 1 (вільний)




    Korolyuk, O. Ya.
    Hypertriclyceridemia is associated with long-term risk of cardiovascular events and specific comorbidity in very high-risk hypertensive patients / O. Ya. Korolyuk, O. M. Radchenko // The Ukrainian biochemical journal. - 2020. - Vol. 92, № 2. - P8-19


MeSH-головна:
ГИПЕРТЕНЗИЯ -- HYPERTENSION (осложнения)
ГИПЕРТРИГЛИЦЕРИДЕМИЯ -- HYPERTRIGLYCERIDEMIA (патофизиология)
КОМОРБИДНОСТЬ -- COMORBIDITY
Анотація: Although hypertriglyceridemia (HTG) frequently occurs in hypertensive patients and may increase cardiovascular risk, the need for and manner of its reduction remain controversial. The objectives of this study were to compare lipid profiles, parameters of glucose homeostasis, comorbidity, and 5-year survival without cardiovascular events in very high-risk hypertensive (VHRH) patients with and without HTG, who received moderate intensity atorvastatin therapy. After initial assessment, 107 VHRH subjects were divided into two groups, i.e., without (n = 49) and with HTG (n = 58). During observation once annually patients were interviewed about prior hospitalizations with further screening for diabetes. Combined endpoint included­ hospitalization due acute myocardial infarction, decompensated heart failure, stroke or death. Survival was analyzed by Kaplan-Meier’s method. Nonparametric methods were used for statistical analysis. Higher median­ values of logarithmic value of triglycerides-to-HDL-cholesterol ratio, lipid accumulation product, fasting insulin, and HOMA index were observed in group 2 (P 0.002) that reflect predominance of small dense LDL particles, ectopic lipid deposition and insulin resistance. Patients with HTG more commonly had type 2 diabetes (58.6% vs 34.5%, including first-detected cases during initial assessments and observation, P
Дод.точки доступу:
Radchenko, O. M.

Вільних прим. немає